Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NYX-783 for Opioid Use Disorder
NCT05447286Phase 1Completed
- Sponsor
- Yale University
- Start
- May 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of NYX-783 in opioid use disorder (OUD), sponsored by Yale University. Started May 2023; status: completed.
02
Drugs
NYX-783
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05447286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05447286.